Featured News Image Podcast episodes | Dec 5 2024 Wu Tsai Neurosciences Institute How to live in a world without free will This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view we should all stop judging one another (and ourselves) for behaviors we can't control Image Research news | Nov 25 2024 Wu Tsai Neurosciences Institute Dopamine and serotonin work in opposition to shape learning New research from the Malenka lab reveals that reward-based learning requires the two neuromodulators to balance one another's influence. Image Podcast episodes | Nov 21 2024 Wu Tsai Neurosciences Institute The power of psychedelics meets the power of placebo We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression. Image Knight Initiative news | Nov 12 2024 Knight Initiative for Brain Resilience Unlocking the secrets of ketosis With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism. News Filter & Sort Sort by ThemeNeuroHealth NeuroDiscovery News TypeResearch news Podcast episodes Sort by Newest to oldest Oldest to newest Image Podcast episodes | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2) This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. Image Podcast episodes | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine. Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
Image Podcast episodes | Dec 5 2024 Wu Tsai Neurosciences Institute How to live in a world without free will This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view we should all stop judging one another (and ourselves) for behaviors we can't control
Image Research news | Nov 25 2024 Wu Tsai Neurosciences Institute Dopamine and serotonin work in opposition to shape learning New research from the Malenka lab reveals that reward-based learning requires the two neuromodulators to balance one another's influence.
Image Podcast episodes | Nov 21 2024 Wu Tsai Neurosciences Institute The power of psychedelics meets the power of placebo We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.
Image Knight Initiative news | Nov 12 2024 Knight Initiative for Brain Resilience Unlocking the secrets of ketosis With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.
Image Podcast episodes | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter perception? (Part 2) This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain.
Image Podcast episodes | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine.
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
